Literature DB >> 26940971

Stem cells, biomarkers and genetic profiling: approaching future challenges in Urology.

Mariangela Mancini1, Michele Zazzara1, Filiberto Zattoni1.   

Abstract

Urological research is facing future challenges, the most difficult one is the fast and meaningful transfer of the massive amount of data from research basic to clinical practice. Between the most important issues that research should focus in the next years are targeting of tumor stem cells, clinical application of biomarkers, and wide application of genetic profiling of urological neoplasms. Several clinical implications are expected, from diagnosis to selection of candidates for different treatment modalities, to modulation of sequential treatment plans, to prognosis. A number of clinical trials based on research data from the hottest issues are in the pipeline. In this review, we will focus on new insights from recent work worlwide in urological research, with particular attention to high-risk nonmuscle-invasive and muscle-invasive bladder cancer, prostate cancer, and kidney cancer. Cancer care is moving towards a personalized approach in patient management. The most important issues in urological research point strongly in this direction and show an enormous potential for the rapid landing of Urology in the era of personalized medicine.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26940971     DOI: 10.5301/uro.5000165

Source DB:  PubMed          Journal:  Urologia        ISSN: 0391-5603


  5 in total

1.  Diagnostic Performance of Preoperative Choline-PET/CT in Patients Undergoing Salvage Lymph Node Dissection for Recurrent Prostate Cancer: A Multicenter Experience.

Authors:  Łukasz Nyk; Hubert Kamecki; Wojciech Krajewski; Bartosz Małkiewicz; Tomasz Szydełko; Markiian Kubis; Marcin Słojewski; Piotr Kryst; Sławomir Poletajew; Wojciech Malewski
Journal:  Tomography       Date:  2022-04-11

2.  Genetic Profiling of Glucocorticoid (NR3C1) and Mineralocorticoid (NR3C2) Receptor Polymorphisms before Starting Therapy with Androgen Receptor Inhibitors: A Study of a Patient Who Developed Toxic Myocarditis after Enzalutamide Treatment.

Authors:  Manuel Morales; Pablo Martín-Vasallo; Julio Ávila
Journal:  Biomedicines       Date:  2022-05-29

3.  Nonsense-Mediated Decay Targeted RNA (ntRNA): Proposal of a ntRNA-miRNA-lncRNA Triple Regulatory Network Usable as Biomarker of Prognostic Risk in Patients with Kidney Cancer.

Authors:  Zhiyue Zhou; Fuyan Hu; Dan Huang; Qingjia Chi; Nelson L S Tang
Journal:  Genes (Basel)       Date:  2022-09-15       Impact factor: 4.141

4.  Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific.

Authors:  Brian Duggan; Declan O'Rourke; Neil Anderson; Cherith N Reid; Joanne Watt; Hugh O'Kane; Ruth Boyd; David Curry; Mark Evans; Michael Stevenson; Mary Jo Kurth; John V Lamont; Peter Fitzgerald; Mark W Ruddock
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 5.  The Bladder EpiCheck Test as a Non-Invasive Tool Based on the Identification of DNA Methylation in Bladder Cancer Cells in the Urine: A Review of Published Evidence.

Authors:  Mariangela Mancini; Marialaura Righetto; Sara Zumerle; Monica Montopoli; Filiberto Zattoni
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.